Glyphosate and the key characteristics of an endocrine disruptor: A review.


Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
May 2021
Historique:
received: 08 05 2020
revised: 30 09 2020
accepted: 12 10 2020
pubmed: 3 11 2020
medline: 11 3 2021
entrez: 2 11 2020
Statut: ppublish

Résumé

Glyphosate is a large-spectrum herbicide that was introduced on the market in 1974. Due to its important impact on the crop industry, it has been significantly diversified and expanded being considered the most successful herbicide in history. Currently, its massive use has led to a wide environmental diffusion and its human consumption through food products has made possible to detect it in urine, serum, and breast milk samples. Nevertheless, recent studies have questioned its safety and international agencies have conflicting opinions about its effects on human health, mainly as an endocrine-disrupting chemical (EDC) and its carcinogenic capacity. Here, we conduct a comprehensive review where we describe the most important findings of the glyphosate effects in the endocrine system and asses the mechanistic evidence to classify it as an EDC. We use as guideline the ten key characteristics (KCs) of EDC proposed in the expert consensus statement published in 2020 (La Merrill et al., 2020) and discuss the scopes of some epidemiological studies for the evaluation of glyphosate as possible EDC. We conclude that glyphosate satisfies at least 8 KCs of an EDC, however, prospective cohort studies are still needed to elucidate the real effects in the human endocrine system.

Identifiants

pubmed: 33131751
pii: S0045-6535(20)32814-9
doi: 10.1016/j.chemosphere.2020.128619
pii:
doi:

Substances chimiques

Endocrine Disruptors 0
Herbicides 0
Glycine TE7660XO1C

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

128619

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Juan P Muñoz (JP)

Instituto de Alta Investigación (IAI), Universidad de Tarapacá, Antofagasta 1520, Arica, 1000000, Chile. Electronic address: juanpablomunozbarrera@gmail.com.

Tammy C Bleak (TC)

Instituto de Alta Investigación (IAI), Universidad de Tarapacá, Antofagasta 1520, Arica, 1000000, Chile. Electronic address: tammycb09@gmail.com.

Gloria M Calaf (GM)

Instituto de Alta Investigación (IAI), Universidad de Tarapacá, Antofagasta 1520, Arica, 1000000, Chile; Center for Radiological Research, VC11-218, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA. Electronic address: gmc24@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH